2024 ICD-10-CM Diagnosis Code C41.9

by

Malignant neoplasm of bone and articular cartilage, unspecified

  • C41.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Malignant neoplasm of bone and articular cartilage, unsp
  • The 2024 edition of ICD-10-CM C41.9 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C41.9 – other international versions of ICD-10 C41.9 may differ.

The following code(s) above C41.9 contain annotation back-references

 that may be applicable to C41.9:

  • C00-D49  Neoplasms
  • C40-C41  Malignant neoplasms of bone and articular cartilage
  • C41  Malignant neoplasm of bone and articular cartilage of other and unspecified sites

Approximate Synonyms

  • Cancer of the articular cartilage
  • Cancer of the bone
  • Cancer of the bone and cartilage
  • Cancer of the bone, ewings sarcoma
  • Cancer of the bone, osteosarcoma
  • Chondrosarcoma
  • Ewing’s sarcoma of bone
  • Malignant neoplasm of bone
  • Osteosarcoma of bone
  • Primary malignant neoplasm of articular cartilage
  • Primary malignant neoplasm of bone

ICD-10-CM C41.9 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
  • 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
  • 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc

Convert C41.9 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to C41.9: